---
name: Antibiotic Resistance
slug: antibiotic-resistance
type: evolutionary_process
status: running
version: ∞.ongoing
released: "~2,000,000,000 BCE"
maintainer: natural_selection
dependencies:
  - bacteria
  - antibiotics
  - horizontal_gene_transfer
  - human_overconfidence
license: GPLv0 (nature retains all rights)
tags:
  - microbiology
  - public-health
  - arms-race
  - slow-disaster
  - unresolved
---

Antibiotic Resistance

What it actually is

Evolution doing exactly what it was designed to do, at a speed humans find inconvenient.

How it works

A population of bacteria is exposed to an antibiotic. Most die. A few carry a mutation that interferes with the drug's mechanism. Those survivors reproduce. Their offspring inherit the mutation. The drug stops working. Nobody is surprised except, repeatedly, us.

The mechanisms are embarrassingly elegant:

Enzymatic degradation: the bacterium produces a protein that dismantles the antibiotic before it can act (see: beta-lactamase)
Efflux pumps: the cell ejects the drug like a bouncer removing a guest
Target modification: the antibiotic's binding site is subtly altered so the drug no longer fits
Reduced permeability: the membrane simply stops letting the drug in

Genes encoding these tricks spread not just through reproduction but through horizontal gene transfer, meaning resistance can jump between species. A bacteria does not need to evolve the solution. It can borrow it.

Features

Fully automated
Runs continuously in hospitals, farms, rivers, and soil
Requires no human input, though human input accelerates it considerably
Compatible with all known antibiotics, given enough time
Scales with dosage pressure

Known bugs

There are no bugs. This is the intended behavior of the underlying system (natural selection). The bug is in the framing: we called antibiotics a solution when they were always a head start.

"We thought we had won. We had paused." — reconstructed sentiment, 1950s microbiology

Configuration

# Default resistance_acquisition settings
selective_pressure: high          # correlates with antibiotic misuse
mutation_rate: low_per_cell       # but population sizes compensate
gene_transfer_enabled: true       # cannot be disabled
antibiotic_stewardship: optional  # tragically
agricultural_use_restricted: false # in most jurisdictions
new_antibiotic_pipeline: sparse   # funding dried up ~1980s

Warning: Setting antibiotic_stewardship: optional in production environments is not recommended. Current default observed in most global deployments.

Error codes

Code	Name	Description
`RES_001`	MRSA	Methicillin-resistant S. aureus. Stable in most hospital environments.
`RES_002`	CRKP	Carbapenem-resistant K. pneumoniae. Last-resort drug ineffective.
`RES_003`	XDR-TB	Extensively drug-resistant tuberculosis. Treats your treatment plan as a suggestion.
`RES_004`	PAN_RESIST`	Resistance to all available agents. No fallback. Stack trace ends here.

Edge cases

Resistance genes can persist in bacterial populations even without antibiotic pressure, meaning you cannot undo exposure by stopping
Soil bacteria have carried resistance genes for millions of years, predating human medicine entirely, which is humbling
Phage therapy exists as an alternative pathway but remains underfunded and under-researched, sitting at status: experimental

FAQ

Can we fix this? Partially. Antimicrobial stewardship, new drug classes, phage therapy, and rapid diagnostics all slow the process. None reverse it.

Why are new antibiotics not being developed? Pharmaceutical economics. A drug you take for ten days generates less revenue than a drug you take forever.

Is this the end of modern medicine? It is the end of modern medicine as a static achievement. It was always supposed to be a moving effort.

drafting spec…